Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

arglecin

Known as: 6-(3-guanidino-propyl)-3-isobutyl-2-(1H)- pyrazinone 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
To date, studies describing myxobacterial secondary metabolites have been relatively scarce in comparison to those addressing… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 4
  • table 2
2015
2015
The intermolecular cycloaddition of pyrazinone precursors with alkyne substrates was evaluated. The resulting regioisomeric [2.2… Expand
2010
2010
The invention provides novel substituted 6-arylamino pyridone sulfonamides and 6 arylamino pyrazinone sulfonamides represented by… Expand
2008
2008
Akt kinases are attractive targets for small molecule drug discovery because of their key role in tumor cell survival… Expand
Highly Cited
2004
Highly Cited
2004
In an effort to discover potent, clinically useful thrombin inhibitors, a rapid analogue synthetic approach was used to explore… Expand
1999
1999
Cyclization of (S,S)-alpha-[(1-phenylethyl)amino]-alpha-(2-iodophenyl)acetonitrile with (COCl)(2) in toluene or chlorobenzene… Expand
1977
1977
The requirements for maximum production of arglecin, 3-isobuty1-6-(3-guanidinopropyl)-2(1H)pyrazinone, by Streptomyces… Expand
1972
1972
1971
1971
A new streptomycete metabolite named arglecin was isolated from the culture filtrates of the strains KA57-AG3, KB59-M1 and the… Expand